Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.45
-0.03-2.03%
At close: -
$1.44
-0.01-0.69%
After Hours: May 23, 5:35 PM EDT
Comments
Loading...
Edge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Geron Stock Price, Quotes and Forecasts | NASDAQ:GERN | Benzinga
Explore Geron stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for GERN.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Geron (GERN) stock?
You can purchase shares of Geron (NASDAQ:GERN) through any online brokerage.
Who are Geron (GERN) competitors?
Other companies in Geron’s space includes: Immunome (NASDAQ:IMNM), Gyre Therapeutics (NASDAQ:GYRE), Syndax Pharmaceuticals (NASDAQ:SNDX), Replimune Group (NASDAQ:REPL) and CareDx (NASDAQ:CDNA).
What is the forecast, or price target, for Geron (GERN) stock?
Geron has a consensus price target of $5.79.
What is the current price for Geron (GERN)?
The stock price for Geron (NASDAQ: GERN) is $1.44 last updated May 23, 2025 at 5:35 PM EDT.
Does Geron (GERN) pay a dividend?
There are no upcoming dividends for Geron.
When is Geron (NASDAQ:GERN) reporting earnings?
Geron’s Q2 earnings are confirmed for Thursday, August 7, 2025.
Is Geron (GERN) going to split?
There is no upcoming split for Geron.
What sector and industry does Geron (GERN) operate in?
Geron is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
